5.1 Care Setting Determination and Acuity Stratification

Quick Overview: Heart failure care planning begins with rapid, precise acuity stratification to match the patient's clinical instability and pathophysiological trajectory with the appropriate site of care. Selecting among the outpatient heart failure clinic, observation unit, acute inpatient telemetry unit, or cardiac intensive care unit (CICU) depends on objective hemodynamics, end-organ perfusion, biomarker elevation, and response to initial therapy. Systematically applying validated risk engines—such as the ADHERE risk tree, OPTIMIZE-HF, and MAGGIC score—alongside structured discharge readiness criteria and multidisciplinary referrals directly prevents avoidable hospital readmissions and lowers in-hospital and post-discharge mortality.

---

Site-of-Care Triage and Acuity Determination

Clinical decision-making during heart failure decompensation requires determining whether the patient can be managed safely in an ambulatory setting, requires short-stay observation, mandates an inpatient acute telemetry admission, or requires advanced hemodynamic support in a CICU.

                             ┌──────────────────────────────────────┐
                             │ Acute Heart Failure Presentation     │
                             └──────────────────┬───────────────────┘
                                                │
                 ┌──────────────────────────────┼──────────────────────────────┐
                 ▼                              ▼                              ▼
      ┌────────────────────┐         ┌────────────────────┐         ┌────────────────────┐
      │ Hemodynamically    │         │ Stable, Known HF;  │         │ Cardiogenic Shock, │
      │ Stable; Mild Fluid │         │ Moderate Fluid;    │         │ Refractory Hypoxia,│
      │ Retention          │         │ Normal Troponin    │         │ Malignant VT/VF    │
      └──────────┬─────────┘         └──────────┬─────────┘         └──────────┬─────────┘
                 ▼                              ▼                              ▼
      ┌────────────────────┐         ┌────────────────────┐         ┌────────────────────┐
      │ Ambulatory HF      │         │ Emergency          │         │ Cardiac Intensive  │
      │ Clinic / Infusion  │         │ Observation Unit   │         │ Care Unit (CICU)   │
      │ (Discharge Home)   │         │ (24-48 hr Diuresis)│         │ (Inotropes/MCS)    │
      └────────────────────┘         └────────────────────┘         └────────────────────┘

1. Outpatient Heart Failure Clinic

• Target Population: Patients with mild, gradual volume reaccumulation (1 to 2 kg above dry weight), chronic stable NYHA Class II–III symptoms, clear mentation, intact renal perfusion, and preserved hemodynamics (systolic blood pressure [SBP] ≥ 100 mmHg).
• Interventions: Oral diuretic adjustments, temporary addition of a second diuretic (e.g., oral metolazone or chlorothiazide) as "sequential nephron blockade," single outpatient intravenous loop diuretic boluses in a dedicated heart failure infusion suite, and routine guideline-directed medical therapy (GDMT) up-titration.

2. Emergency Observation Unit / Clinical Decision Unit (CDU)

• Eligibility Criteria: Mild-to-moderate decompensation without high-risk markers; known cardiomyopathy etiology; SBP ≥ 100-110 mmHg; stable baseline renal function; cardiac troponin levels non-elevated or stable without evidence of acute coronary syndrome (ACS); clear response to an initial IV loop diuretic dose.
• Operational Window: 24 to 48 hours maximum. Patients receive protocolized IV diuretic boluses or low-dose infusions, serial basic metabolic panels, and bedside assessment of decongestion. If euvolemia is achieved and oral diuretic therapy is verified, the patient is discharged home with close outpatient follow-up. Failure to decongest within 24 to 36 hours triggers conversion to full inpatient admission.

3. Acute Inpatient Telemetry Unit

• Eligibility Criteria: Moderate-to-severe volume overload refractory to initial emergency diuresis; new-onset heart failure requiring extensive diagnostic evaluation (e.g., echocardiography, ischemic workup); worsening cardiorenal syndrome (creatinine rise ≥ 0.5 mg/dL); severe peripheral or anasarca edema; symptomatic electrolyte disturbances (e.g., serum potassium <3.0 or >5.8 mEq/L, serum sodium <125 mEq/L); or suspected non-sustained ventricular arrhythmias requiring continuous ECG monitoring.

4. Cardiac Intensive Care Unit (CICU)

• Mandatory Indications:
  • Hemodynamic Instability / Cardiogenic Shock: SCAI Stage C (Classic), D (Deteriorating), or E (Extremis); persistent SBP <85-90 mmHg with signs of hypoperfusion (cool, clammy skin, lactic acidosis >2.0 mmol/L, altered sensorium, oliguria <0.5 mL/kg/h).
  • Invasive Hemodynamic & Vasoactive Support: Requirement for continuous IV inotropes (milrinone, dobutamine) or vasopressors (norepinephrine, epinephrine), pulmonary artery catheter (PAC / Swan-Ganz) placement, or temporary mechanical circulatory support (Impella, intra-aortic balloon pump [IABP], or venoarterial extracorporeal membrane oxygenation [VA-ECMO]).
  • Severe Respiratory Compromise: Refractory hypoxemia (SpO₂ <90% on high-flow oxygen) or severe respiratory acidosis (pH <7.25, PaCO₂ >50 mmHg) requiring continuous non-invasive positive pressure ventilation (BiPAP/CPAP) or endotracheal intubation.
  • Electrical Storm: Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF), or recurrent implantable cardioverter-defibrillator (ICD) therapies (3 or more separate VT/VF episodes within 24 hours).

---

Clinical Risk Prediction Tools and Prognostic Engines

Quantifying in-hospital and long-term risk guides the intensity of nursing surveillance, telemetry utilization, and multidisciplinary intervention.

Pathophysiological Rationale of the ADHERE Decision Tree

In the landmark Acute Decompensated Heart Failure National Registry (ADHERE) analysis of 65,275 hospitalization episodes (drawn from a registry of more than 100,000), baseline blood urea nitrogen (BUN) ≥ 43 mg/dL emerged as the single most powerful predictor of in-hospital death. Elevated BUN in heart failure does not simply reflect reduced glomerular filtration; it reflects intense neurohormonal activation. Enhanced sympathetic nervous system (SNS) tone and arginine vasopressin (AVP) hypersecretion stimulate excessive urea reabsorption in the proximal and collecting renal tubules. Combined with systolic blood pressure <115 mmHg (indicating exhausted cardiac contractile reserve and low forward stroke volume) and serum creatinine ≥ 2.75 mg/dL (signifying advanced cardiorenal failure), this triad identifies patients at extreme risk who cannot be managed in low-acuity areas.

---

Acute Admission vs. Observation Criteria

┌─────────────────────────────────────────────────────────────────────────────┐
│                     Site of Care Determination Criteria                     │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Care Setting             │ Concrete Clinical Indicators & Biomarker Profiles│
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Observation Unit / CDU   │ • Known chronic cardiomyopathy with mild volume  │
│ (Planned stay <24-48 hr) │   overload (weight gain <5-8 lbs)                │
│                          │ • SBP ≥100-110 mmHg; Heart Rate 60-100 bpm       │
│                          │ • Normal baseline troponin; stable eGFR          │
│                          │ • Rapid response to first dose of IV loop        │
│                          │   diuretic (urine output >500 mL in 2 hr)        │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Inpatient Telemetry Floor│ • Decompensation unresponsive to 1-2 IV doses    │
│ (Acute Admission)        │ • New-onset uncharacterized heart failure        │
│                          │ • Rising troponin / acute subendocardial strain  │
│                          │ • Cardiorenal syndrome (creatinine bump ≥0.5)    │
│                          │ • Syncope, pre-syncope, or high-grade ectopy     │
│                          │ • Significant electrolyte imbalance (K+ <3.0     │
│                          │   or >5.8 mEq/L, Na+ <125 mEq/L)                 │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Cardiac Intensive Care   │ • SBP <85-90 mmHg, MAP <65 mmHg, cold extremities│
│ (CICU / Critical Care)   │ • Serum lactate >2.0 mmol/L; arterial pH <7.25   │
│                          │ • Need for continuous inotrope (milrinone,       │
│                          │   dobutamine) or vasopressor infusions           │
│                          │ • Invasive PAC or mechanical support (Impella)   │
│                          │ • Recurrent VT/VF or multiple ICD shocks         │
└──────────────────────────┴──────────────────────────────────────────────────┘

---

Inpatient Discharge Readiness Criteria

Premature discharge before adequate decongestion is a major, preventable contributor to the roughly 20% to 25% 30-day readmission rate seen in Medicare populations. The certified heart failure nurse must systematically verify all six core discharge criteria before authorizing discharge:

1. Clinical Euvolemia Confirmed: Absence of orthopnea, paroxysmal nocturnal dyspnea (PND), resting dyspnea, and bendopnea; jugular venous distention (JVD) <8 cm H₂O; resolution of hepatojugular reflux; absence of ascites; and resolution or return to chronic baseline of lower-extremity edema.
2. Oral Diuretic Regimen Stabilized for ≥ 24 Hours: The patient must be converted from IV to the planned discharge oral diuretic regimen for at least 24 consecutive hours prior to leaving the hospital. This confirms that intestinal absorption is adequate, oral bioavailability is sufficient, and urine output remains balanced without rebound weight gain.
3. Stable Renal Function and Electrolytes: Serum creatinine and BUN must be stable (no continuous upward trajectory) for ≥ 24-48 hours. Serum potassium must be within the target safety range (4.0-5.0 mEq/L), and magnesium should be repleted (many protocols target ≥ 2.0 mg/dL).
4. GDMT Initiated or Optimized: Inpatient initiation of foundational GDMT (the "Four Pillars": ARNI/ACEi/ARB, evidence-based beta-blocker, MRA, and SGLT2 inhibitor) is recommended once the patient is hemodynamically stable; in STRONG-HF, rapid in-hospital initiation and early up-titration with close follow-up reduced 180-day death or HF readmission.
5. Patient and Caregiver Education Completed: Mastery of the "Heart Failure Action Plan" (Green/Yellow/Red zones), daily weighing procedure (same scale, morning, after voiding, before breakfast), sodium restriction (2,000-3,000 mg/day), fluid restriction (1.5-2.0 L/day if hyponatremic <130 mEq/L), and emergency action triggers.
6. 7-Day Outpatient Follow-up Confirmed: An outpatient clinic appointment with an advanced heart failure practitioner or specialized nurse must be scheduled within 7 days of discharge. The 2022 guideline rates early follow-up, generally within 7 days, as reasonable (Class 2a), and hospitals with higher early follow-up rates have lower 30-day readmission rates.

---

Multidisciplinary Referral Pathways

Comprehensive heart failure care requires timely, proactive coordination across specialized disciplines rather than fragmented consultations.

                         ┌─────────────────────────────────────────┐
                         │   Multidisciplinary HF Care Network     │
                         └────────────────────┬────────────────────┘
                                              │
     ┌────────────────────┬───────────────────┼───────────────────┬────────────────────┐
     ▼                    ▼                   ▼                   ▼                    ▼
┌───────────────┐  ┌───────────────┐   ┌───────────────┐   ┌───────────────┐   ┌───────────────┐
│Advanced HF    │  │Cardiac        │   │Clinical       │   │Registered     │   │Palliative     │
│Cardiologist   │  │Rehab (Phase 2)│   │Pharmacy       │   │Dietitian      │   │Care Services  │
│• EF <25%      │  │• NYHA II-III  │   │• Med reconcil.│   │• 2-3 g Na/day │   │• Refractory Sx│
│• Inotrope-dep.│  │• ↑ Peak VO2   │   │• PAPs/340B    │   │• Cachexia Mgt │   │• Goals of Care│
│• LVAD/Tx eval │  │• Class 2a rec.│   │• Titration    │   │• Renal diet   │   │• ICD deactiv. │
└───────────────┘  └───────────────┘   └───────────────┘   └───────────────┘   └───────────────┘

• Advanced Heart Failure Cardiology: Triggered by "I-NEED-HELP" criteria: Inotropes required, NYHA Class IIIB/IV, End-organ dysfunction, Ejection fraction ≤ 25%, Defibrillator shocks, Hospitalizations (more than one in the past 12 months), Edema despite escalating diuretics, Low blood pressure (SBP persistently <90–100 mmHg), Prognostic medication intolerance (forced down-titration of beta-blockers or RAASi).
• Electrophysiology (EP): For primary or secondary prevention ICD placement; cardiac resynchronization therapy (CRT) evaluation in patients with LVEF ≤ 35%, sinus rhythm, and left bundle branch block (LBBB) with QRS duration ≥ 130-150 ms; and catheter ablation for atrial fibrillation or refractory ventricular ectopy.
• Cardiac Rehabilitation: Exercise training is a Class 1 recommendation, and a formal cardiac rehabilitation program (Phase II) is Class 2a, for medically stable chronic heart failure. It attenuates peripheral skeletal muscle wasting, enhances endothelial function, and increases peak oxygen consumption (VO₂); in HF-ACTION, exercise training modestly reduced hospitalization after adjustment for prognostic factors.
• Clinical Pharmacy: Performs comprehensive admission and discharge medication reconciliation, identifies harmful drug-drug interactions, coordinates medication access via Patient Assistance Programs (PAPs) and 340B pricing, and manages nurse-pharmacist collaborative GDMT titration clinics.
• Registered Dietitian (RD): Individualizes dietary sodium education, assesses micronutrient deficiencies, and addresses cardiac cachexia (involuntary, non-edematous weight loss of ≥5% within 12 months), which carries a poor prognosis.
• Medical Social Work & Case Management: Evaluates social determinants of health (SDOH), organizes durable medical equipment (home scales, blood pressure monitors), secures non-emergency medical transportation (NEMT), and navigates Medicare/Medicaid coverage.
• Home Health Nursing: Provides skilled nursing visits within about 48 hours of discharge to assess vitals, verify dry weights, review medications, inspect pill organizers, and report early weight increases to the outpatient team before fluid retention mandates emergency re-admission.
• Palliative Care: Indicated at any point along the heart failure trajectory—not merely at end of life—to relieve burdensome physical symptoms (dyspnea, pain, fatigue, nausea), facilitate goals-of-care dialogues, document advance directives (POLST/MOLST), support family caregivers, and coordinate ICD tachytherapy deactivation.

---

Clinical Case Scenario: Care Setting Selection & Safe Transition

A 71-year-old male with ischemic cardiomyopathy (LVEF 22%) presents to the emergency department with a 10-pound weight gain over three weeks, marked bilateral lower-extremity pitting edema extending to the mid-thighs, prominent jugular venous distention to the angle of the jaw, and resting orthopnea requiring four pillows.

• Vital Signs & Labs: Blood pressure 104/68 mmHg, heart rate 88 bpm (sinus rhythm), SpO₂ 91% on ambient air. Admission labs reveal a BUN of 48 mg/dL, serum creatinine of 2.1 mg/dL (baseline 1.4 mg/dL), and cardiac troponin within normal limits.
• Acuity Stratification: The emergency physician considers placing the patient in the 24-hour observation unit. However, the heart failure nurse points out that based on the ADHERE risk engine, the patient's BUN >43 mg/dL and SBP <115 mmHg place him in an elevated mortality risk tier. Furthermore, anasarca with a 10-pound excess fluid burden and an acute creatinine elevation from 1.4 to 2.1 mg/dL (cardiorenal syndrome) cannot be safely decongested and stabilized within 24 to 48 hours. The patient is appropriately admitted to the inpatient telemetry floor.
• Inpatient Management & Discharge Planning: Over four days of IV furosemide infusion, the patient loses 5.2 kg. His JVD drops to <7 cm H₂O, orthopnea resolves, and his serum creatinine stabilizes at 1.5 mg/dL with a potassium of 4.3 mEq/L.
• Discharge Transition: Twenty-four hours prior to planned discharge, the nurse transitions him to oral torsemide 40 mg daily. Over that final 24-hour period, the patient maintains a stable weight, stable vitals, and normal electrolytes. The nurse completes teach-back education with the patient and his daughter, schedules home health nursing for post-discharge day 2, and confirms an in-person outpatient cardiology follow-up visit on post-discharge day 6. By adhering strictly to discharge readiness criteria, the team successfully prevents early decompensation.

---

CHFN Exam Traps & Clinical Pearls

[!WARNING] Exam Trap: Avoid discharging a heart failure patient on the same day the IV diuretic was converted to an oral regimen. Observing the oral regimen for about 24 hours before discharge is a widely used readiness criterion to prove oral bioavailability, ensure adequate gut absorption (free of bowel wall edema), and verify stable 24-hour weight and electrolytes.

[!IMPORTANT] Clinical Pearl: In the ADHERE mortality tree, the top three predictive variables are BUN ≥ 43 mg/dL, Systolic BP <115 mmHg, and Serum Creatinine ≥ 2.75 mg/dL. If an exam question asks which baseline parameter most powerfully predicts in-hospital mortality in acute decompensated heart failure, the answer is elevated BUN, not ejection fraction or BNP level.

[!TIP] Exam Trap: Do not confuse observation unit criteria with telemetry criteria. A patient with severe cardiorenal syndrome, new-onset uncharacterized heart failure, rising troponin, or severe electrolyte derangements (K⁺ <3.0 or >5.8 mEq/L) is never an observation unit candidate, regardless of whether emergency department beds are crowded.